GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,093,000 | -28.7% | 71,126 | +5.4% | 0.83% | -19.0% |
| Q2 2022 | $2,936,000 | -0.3% | 67,459 | -0.2% | 1.03% | +3.4% |
| Q1 2022 | $2,945,000 | -1.2% | 67,604 | +0.0% | 1.00% | +11.4% |
| Q4 2021 | $2,980,000 | +14.9% | 67,577 | -0.4% | 0.89% | +10.9% |
| Q3 2021 | $2,594,000 | -5.9% | 67,876 | -2.0% | 0.80% | -2.1% |
| Q2 2021 | $2,758,000 | +11.3% | 69,259 | -0.3% | 0.82% | +5.5% |
| Q1 2021 | $2,479,000 | -4.0% | 69,449 | -1.0% | 0.78% | -26.0% |
| Q4 2020 | $2,582,000 | -2.6% | 70,165 | -0.4% | 1.05% | -4.4% |
| Q3 2020 | $2,652,000 | -8.3% | 70,468 | -0.6% | 1.10% | -14.6% |
| Q2 2020 | $2,893,000 | +5.4% | 70,916 | -2.1% | 1.29% | -1.9% |
| Q1 2020 | $2,746,000 | -19.0% | 72,469 | +0.4% | 1.32% | -2.3% |
| Q4 2019 | $3,392,000 | +8.8% | 72,185 | -1.2% | 1.35% | +4.6% |
| Q3 2019 | $3,117,000 | +5.9% | 73,037 | -0.7% | 1.29% | +0.3% |
| Q2 2019 | $2,944,000 | -5.2% | 73,559 | -1.0% | 1.28% | -7.5% |
| Q1 2019 | $3,105,000 | +9.9% | 74,309 | +0.5% | 1.39% | -6.7% |
| Q4 2018 | $2,826,000 | -6.2% | 73,960 | -1.4% | 1.49% | +7.4% |
| Q3 2018 | $3,014,000 | -0.9% | 75,022 | -0.5% | 1.38% | -4.3% |
| Q2 2018 | $3,040,000 | +1.8% | 75,412 | -0.5% | 1.45% | -5.6% |
| Q1 2018 | $2,985,000 | +10.4% | 75,795 | -0.5% | 1.53% | +10.5% |
| Q4 2017 | $2,703,000 | -11.6% | 76,214 | +1.2% | 1.39% | -14.4% |
| Q3 2017 | $3,057,000 | -4.3% | 75,290 | +1.6% | 1.62% | -8.3% |
| Q2 2017 | $3,196,000 | +3.9% | 74,111 | +1.6% | 1.76% | -9.2% |
| Q1 2017 | $3,075,000 | +18.4% | 72,941 | +8.1% | 1.94% | +10.1% |
| Q4 2016 | $2,598,000 | -10.9% | 67,475 | -0.2% | 1.76% | -9.2% |
| Q3 2016 | $2,917,000 | -1.4% | 67,630 | -0.9% | 1.94% | -5.6% |
| Q2 2016 | $2,957,000 | +6.4% | 68,225 | -0.5% | 2.06% | +1.6% |
| Q1 2016 | $2,779,000 | +0.3% | 68,540 | -0.2% | 2.03% | -10.8% |
| Q4 2015 | $2,771,000 | – | 68,670 | – | 2.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |